CpG岛甲基化表型结直肠癌治疗的进展
Advances in CpG Island Methylator Phenotype Colorectal Cancer Therapies.
作者信息
Zhang Xiaofei, Zhang Wenjun, Cao Pingan
机构信息
Department of Medical Oncology, Dalian University Affiliated Xinhua Hospital, Dalian, China.
Department of Colorectal Surgery, Dalian University Affiliated Xinhua Hospital, Dalian, China.
出版信息
Front Oncol. 2021 Feb 26;11:629390. doi: 10.3389/fonc.2021.629390. eCollection 2021.
Abstract
With the aging of the population, the incidence of colorectal cancer in China is increasing. One of the epigenetic alterations: CpG island methylator phenotype (CIMP) plays an important role in the incidence of colorectal cancer. Recent studies have shown that CIMP is closely related to some specific clinicopathological phenotypes and multiple molecular phenotypes in colorectal cancer. In this paper, the newest progress of CIMP colorectal cancer in chemotherapeutic drugs, targeted agents and small molecular methylation inhibitors are going to be introduced. We hope to provide potential clinical treatment strategies for personalized and precise treatment of colorectal cancer patients.
摘要
随着人口老龄化，中国结直肠癌的发病率正在上升。表观遗传改变之一：CpG岛甲基化表型（CIMP）在结直肠癌的发病中起重要作用。最近的研究表明，CIMP与结直肠癌的一些特定临床病理表型和多种分子表型密切相关。本文将介绍CIMP结直肠癌在化疗药物、靶向药物和小分子甲基化抑制剂方面的最新进展。我们希望为结直肠癌患者的个性化精准治疗提供潜在的临床治疗策略。
相似文献
1
Advances in CpG Island Methylator Phenotype Colorectal Cancer Therapies.CpG岛甲基化表型结直肠癌治疗的进展
Front Oncol. 2021 Feb 26;11:629390. doi: 10.3389/fonc.2021.629390. eCollection 2021.
2
Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?在CpG岛甲基化表型面板标记中甲基化程度达一半的结直肠癌的临床病理特征与CpG岛甲基化表型高的结直肠癌的临床病理特征是否不同？
Hum Pathol. 2016 Jan;47(1):85-94. doi: 10.1016/j.humpath.2015.09.008. Epub 2015 Sep 25.
3
Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.结直肠癌中的表观遗传学改变：CpG 岛甲基化表型。
Histol Histopathol. 2013 May;28(5):585-95. doi: 10.14670/HH-28.585. Epub 2013 Jan 23.
4
CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer.CpG岛甲基化表型与日本转移性结直肠癌患者基于奥沙利铂和伊立替康的序贯化疗疗效及表皮生长因子受体（EGFR）相关基因突变有关。
Int J Clin Oncol. 2016 Dec;21(6):1091-1101. doi: 10.1007/s10147-016-1017-6. Epub 2016 Jul 19.
5
The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.CpG岛甲基化表型与结直肠癌中的长程表观遗传沉默相关。
Mol Cancer Res. 2008 Apr;6(4):585-91. doi: 10.1158/1541-7786.MCR-07-2158.
6
Isocitrate dehydrogenase 1 R132C mutation occurs exclusively in microsatellite stable colorectal cancers with the CpG island methylator phenotype.异柠檬酸脱氢酶1 R132C突变仅发生于具有CpG岛甲基化表型的微卫星稳定型结直肠癌中。
Epigenetics. 2014 Nov;9(11):1454-60. doi: 10.4161/15592294.2014.971624.
7
Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer.与MGMT启动子甲基化和沉默相关的分子支持结直肠癌中的低CpG岛甲基化表型（CIMP-low）。
Gut. 2007 Nov;56(11):1564-71. doi: 10.1136/gut.2007.119750. Epub 2007 Mar 5.
8
Biological significance of the CpG island methylator phenotype.CpG岛甲基化表型的生物学意义。
Biochem Biophys Res Commun. 2014 Dec 5;455(1-2):35-42. doi: 10.1016/j.bbrc.2014.07.007. Epub 2014 Jul 10.
9
Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review.CpG岛甲基化表型的不同定义与结直肠癌的预后：一项系统评价
Clin Epigenetics. 2016 Mar 2;8:25. doi: 10.1186/s13148-016-0191-8. eCollection 2016.
10
18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.微卫星稳定型结直肠癌中18号染色体杂合性缺失与CpG岛甲基化表型阴性（CIMP-0）相关，与低CIMP和高CIMP呈负相关。
BMC Cancer. 2007 May 2;7:72. doi: 10.1186/1471-2407-7-72.
引用本文的文献
1
Research progress on the diagnostic value of fecal calprotectin in colorectal tumors.粪便钙卫蛋白在结直肠肿瘤诊断价值中的研究进展
Front Med (Lausanne). 2025 Jul 9;12:1626197. doi: 10.3389/fmed.2025.1626197. eCollection 2025.
2
Insight into the role of DNA methylation in prognosis and treatment response prediction of gastrointestinal cancers.深入了解DNA甲基化在胃肠道癌症预后及治疗反应预测中的作用。
Epigenomics. 2025 May;17(7):475-488. doi: 10.1080/17501911.2025.2476380. Epub 2025 Mar 14.
3
Redefining Therapeutic Approaches in Colorectal Cancer: Targeting Molecular Pathways and Overcoming Resistance.重新定义结直肠癌的治疗方法：靶向分子途径与克服耐药性。
Int J Mol Sci. 2024 Nov 21;25(23):12507. doi: 10.3390/ijms252312507.
4
Early colorectal cancer diagnosis: A novel methylated stool DNA model enhanced the diagnostic efficiency.早期结直肠癌诊断：一种新型甲基化粪便DNA模型提高了诊断效率。
United European Gastroenterol J. 2025 Apr;13(3):402-415. doi: 10.1002/ueg2.12696. Epub 2024 Nov 2.
5
Deep learning-based histological predictions of chromosomal instability in colorectal cancer.基于深度学习的结直肠癌染色体不稳定性组织学预测
Am J Cancer Res. 2024 Sep 15;14(9):4495-4505. doi: 10.62347/JYND6488. eCollection 2024.
6
Unmasking early colorectal cancer clues: in silico and in vitro investigation of downregulated IGF2, SOCS1, MLH1, and CACNA1G in SSA polyps.揭开早期结直肠癌的线索：SSA 息肉中下调的 IGF2、SOCS1、MLH1 和 CACNA1G 的计算机模拟和体外研究。
Mol Biol Rep. 2024 Jun 14;51(1):764. doi: 10.1007/s11033-024-09683-3.
7
Hypermethylated Colorectal Cancer Tumours Present a Myc-Driven Hypermetabolism with a One-Carbon Signature Associated with Worsen Prognosis.高甲基化结直肠癌肿瘤呈现出由Myc驱动的高代谢，伴有与预后不良相关的一碳代谢特征。
Biomedicines. 2024 Mar 6;12(3):590. doi: 10.3390/biomedicines12030590.
8
Current Status of Cancer Genomics and Imaging Phenotypes: What Radiologists Need to Know.癌症基因组学和影像学表型的现状：放射科医生需要了解的内容。
Radiol Imaging Cancer. 2023 Nov;5(6):e220153. doi: 10.1148/rycan.220153.
9
A Multi-Omics Overview of Colorectal Cancer to Address Mechanisms of Disease, Metastasis, Patient Disparities and Outcomes.结直肠癌的多组学概述：探讨疾病机制、转移、患者差异及预后
Cancers (Basel). 2023 May 26;15(11):2934. doi: 10.3390/cancers15112934.
10
Transcriptomes of the tumor-adjacent normal tissues are more informative than tumors in predicting recurrence in colorectal cancer patients.肿瘤旁正常组织的转录组比肿瘤组织更能预测结直肠癌患者的复发情况。
J Transl Med. 2023 Mar 21;21(1):209. doi: 10.1186/s12967-023-04053-2.
本文引用的文献
1
Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer.结直肠癌中CpG岛甲基化表型（CIMP）的流行病学及分子病理特征
Clin Colorectal Cancer. 2021 Jun;20(2):137-147.e1. doi: 10.1016/j.clcc.2020.09.007. Epub 2020 Oct 12.
2
Targeting the epigenetic regulation of antitumour immunity.靶向抗肿瘤免疫的表观遗传调控。
Nat Rev Drug Discov. 2020 Nov;19(11):776-800. doi: 10.1038/s41573-020-0077-5. Epub 2020 Sep 14.
3
Cancer registration in China and its role in cancer prevention and control.中国的癌症登记及其在癌症防控中的作用。
Lancet Oncol. 2020 Jul;21(7):e342-e349. doi: 10.1016/S1470-2045(20)30073-5.
4
Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC).原发性肿瘤位置作为转移性结直肠癌（mCRC）的预后和预测标志物
Front Oncol. 2020 Jun 16;10:964. doi: 10.3389/fonc.2020.00964. eCollection 2020.
5
Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer.结直肠癌 CpG 岛甲基化表型在全球的流行差异。
BMC Cancer. 2019 Oct 17;19(1):964. doi: 10.1186/s12885-019-6144-9.
6
Epidrugs: targeting epigenetic marks in cancer treatment.表观遗传学药物：癌症治疗中的靶向表观遗传标记。
Epigenetics. 2019 Dec;14(12):1164-1176. doi: 10.1080/15592294.2019.1640546. Epub 2019 Jul 13.
7
Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases.肝动脉灌注地西他滨（5-氮杂-2'-脱氧胞苷）用于不可切除的以肝脏为主的转移瘤患者的I期临床试验。
ESMO Open. 2019 Mar 5;4(2):e000464. doi: 10.1136/esmoopen-2018-000464. eCollection 2019.
8
Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy.结直肠癌的分子分类：BRAF、KRAS、微卫星不稳定性和 CIMP 状态：预后意义和对化疗的反应。
PLoS One. 2018 Sep 6;13(9):e0203051. doi: 10.1371/journal.pone.0203051. eCollection 2018.
9
DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer.人类结直肠癌中 PD-1、CTLA-4、TIM-3、LAG-3、TIGIT、PD-L1 和半乳糖凝集素-9 基因启动子中的 DNA 甲基化和抑制组蛋白
Clin Epigenetics. 2018 Aug 6;10(1):104. doi: 10.1186/s13148-018-0539-3.
10
Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy.奥沙利铂为基础的辅助化疗治疗 III 期结肠癌中甲基化表型的预后价值。
Clin Cancer Res. 2018 Oct 1;24(19):4745-4753. doi: 10.1158/1078-0432.CCR-18-0866. Epub 2018 Jun 19.
Zotero 插件